Opportunity CDC-RFA-CI10-1012

The summary for the Opportunity CDC-RFA-CI10-1012 Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Opportunity CDC-RFA-CI10-1012
	CFDA Number:	93.521
	CFDA Description:	The Affordable Care Act: Building Epidemiology, Laboratory, and Health Information Systems Capacity in the Epidemiology
	Federal Agency Name:	Centers for Disease Control and Prevention
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	CDC-RFA-CI10-1012
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Aug 16, 2010
	Creation Date:	Aug 16, 2010
	Original Closing Date for Applications:	Aug 27, 2010 Letter of Intent Deadline Date: August 9, 2010 Application Deadline Date: August 27, 2010
	Current Closing Date for Applications:	Aug 27, 2010
	Archive Date:	Sep 26, 2010
	Expected Number of Awards:	58
	Estimated Total Program Funding:	$35,900,000
	Federal Grant Award Ceiling:	$0
	Federal Grant Award Floor:	$0
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: ELIGIBILITY Funding under this FOA is intended to continue and enhance capacity for epidemiology, laboratory and health information systems for infectious diseases and other public health threats through the existing ELC program. Eligible applicants that can apply for this funding opportunity are all current ELC grantees and are listed below. These 58 ELC grantees are currently funded under the following ELC Funding Opportunity Numbers: CI04-040: Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Houston TX, Iowa, Illinois, Indiana, Kansas, Kentucky, Los Angeles County CA, Louisiana, Maine, Massachusetts, Michigan, Missouri, Mississippi, Montana, Nebraska, New Jersey, New Mexico, New York, New York City NY, North Carolina, Ohio, Oklahoma, Pennsylvania, Philadelphia PA, Republic of Palau, Rhode Island, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming. CI07-701: Alaska, Arkansas, Chicago IL, Commonwealth of Puerto Rico, Delaware, District of Columbia, Idaho, Maryland, Minnesota, Nevada, North Dakota, Oregon, South Carolina. CI07-702: New Hampshire A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov.
Grant Description: The purpose of this Affordable Care Act funding through the ELC is to enhance public health programs to improve health and help restrain the rate of growth of health care costs through building epidemiology, laboratory, and health information systems capacity in state and local public health departments. Specifically, the Affordable Care Act funding is being made available via this FOA to enhance the ability of state, local, and territorial ELC grantees to strengthen and integrate capacity for detecting and responding to infectious disease and other public health threats in state and local public health departments. The purpose of these enhancements is to provide flexible and multi-purpose resources to address current high-priority infectious disease problems within grantee jurisdictions, as well as new threats as they emerge. This FOA addresses the following three inter-related areas which are fully consistent with and build upon the existing ELC activities: a. Epidemiology Capacity - To ensure staff are well-trained and well-equipped to provide rapid, effective, and flexible response to infectious disease threats. b. Laboratory Capacity - To achieve modern and well-equipped public health laboratories, with well-trained staff, employing high quality laboratory processes and systems that foster communication and appropriate integration between laboratory and epidemiology functions. c. Health Information Systems Capacity - To develop and enhance current health information infrastructure for public health agencies. Working towards modern, standards-based and interoperable systems, that support electronic exchange of information within and between epidemiology and laboratory functions in public health agencies (e.g., systems that support public health surveillance and investigation, laboratory information management systems (LIMS)); among local, state, and federal public health agencies; and between public health agencies and clinical care systems (e.g., health care providers, clinical laboratories). Enhancing electronic exchange of information between public health agencies and clinical care entities will make a critical contribution to health reform in the U.S.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: Centers for Disease Control and Prevention Procurement and Grants Office TIMS Phone 770-488-2700

PGOTIM@cdc.gov [PGOTIM@cdc.gov]
Similar Government Grants: • Patient Protection and Affordable Care Act (ACA), Emerging Infections Programs (EIP), Enhancing Epid...; • Patient Protection and Affordable Care Act Epidemiology and Laboratory Capacity for Infectious Disea...; • Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epi...